论文部分内容阅读
目的:观察促髓生血汤在胃癌术后化疗中的骨髓功能保护作用。方法:将随机抽取的符合研究标准的104例胃癌患者随机分为两组,其中实验组54例,对照组50例,期间两组分别给予静脉化疗2个周期,实验组在化疗期间同时接受口服促髓生血汤治疗,观察两组患者在近期疗效、生活质量评分、化疗期间患者骨髓功能抑制的情况。结果:进行到第2个化疗周期,实验组II至III度出现骨髓功能抑制的患者占20.3%,对比低于对照组(46.7%),两组统计学差异具有显著性(P<0.05)。实验组与对照组的生存质量评分比较,下降出现缓慢,差异具有显著性(P<0.05)。结论:口服促髓生血汤能够有效保护胃癌术后化疗中患者的骨髓功能,缓解化疗后的骨髓抑制,保证胃癌化疗的顺利进行,改善生存质量。
Objective: To observe the effect of promoting the function of bone marrow function of promoting the function of marrow and marrow in the postoperative chemotherapy of gastric cancer. Methods: A total of 104 gastric cancer patients were randomly divided into two groups according to the research criteria, including 54 cases in the experimental group and 50 cases in the control group. The two groups were given 2 cycles of intravenous chemotherapy respectively. The patients in the experimental group received orally simultaneously Adipose Shengshengxue treatment, the two groups of patients in the short term efficacy, quality of life score, patients with bone marrow suppression during chemotherapy. Results: In the second cycle of chemotherapy, 20.3% of the patients with bone marrow function inhibition occurred in the experimental group, which was lower than the control group (46.7%). There was significant difference between the two groups (P <0.05). The quality of life scores of experimental group and control group showed a slow decline, the difference was significant (P <0.05). Conclusion: Oral Shengshen Shengxue Decoction can effectively protect patients’ bone marrow function after chemotherapy and relieve myelosuppression after chemotherapy, so as to ensure the smooth progress of gastric cancer chemotherapy and improve the quality of life.